Linxiang Zeng

The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non‐small cell lung cancer: A systematic analysis and meta‐analysis based on randomized controlled trials

Yiping Wei, Wenxiong Zhang, Qiangyun Liu, 2021, Journal of clinical pharmacy and therapeutics.

MiR-498 inhibits cell migration and invasion by targeting WT 1 and predicts better prognosis in non-small cell lung cancer

Maosheng Liu, Leifeng Chen, Q. Lin, 2016 .

High-frequency oscillatory ventilation combined with partial liquid ventilation in experimental lung injury: effects on lung cell apoptosis

H. Zeng, G. Guo, Linxiang Zeng, 2015, Wiener klinische Wochenschrift.

Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis–Manifested Severe Disease

Binghao Zhao, Jinxiu Ma, Linxiang Zeng, 2021, Frontiers in Pharmacology.